Nurix Therapeutics, Inc. · NASDAQ:NRIX
Ring Christine sold 5,787 Nurix Therapeutics, Inc. shares (Form 4)
Traded Sep 2, 2026 · Filed Sep 2, 2026
On Sep 2, 2026, Ring Christine (Chief Legal Officer) sold 5,787 Nurix Therapeutics, Inc. shares at an average US$25.76 for US$149K under a trading plan, leaving 9,110 shares. Filed Sep 2, 2026 (Form 4).
- Sold
- 5,787 shares
- Price
- US$25.76 average (US$25.69 to US$26.64)
- Value
- US$149K
- Holding after
- 9,110 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Common Stock | Option exercise | 5,787 | US$8.72 | 14,897 | Direct |
| Sep 2, 2026 | Common Stock | Sale | 5,387 | US$25.69 | 9,510 | Direct |
| Sep 2, 2026 | Common Stock | Sale | 400 | US$26.64 | 9,110 | Direct |
Source
Related
- Nurix Therapeutics, Inc.
- Ring Christine
- Nurix Therapeutics, Inc. shareholders
- Form 4 · Ring Christine · Oct 2, 2026
- Form 4 · Ring Christine · Aug 3, 2026
- Form 4 · Ring Christine · Jul 30, 2026
- Form 4 · Ring Christine · Jul 2, 2026
- Form 4 · Ring Christine · Jun 25, 2026
- Form 4 · Hansen Gwenn · Oct 15, 2026
- Form 4 · Gregory Julia P · Oct 14, 2026
- Schedule 13G · Perceptive Advisors LLC · Sep 23, 2026
- Form 4 · Hansen Gwenn · Sep 1, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026